Om oss
Om Guard Therapeutics
Vision, affärsidé & mål
Styrelse
Ledning
Forskning
Njursjukdom
Vetenskaplig grund
Pipeline
RMC-035
GTX-peptider
Investerare
Finansiell kalender
Finansiella rapporter
Aktieinformation
Bolagsstyrning
Bolagsstämma
Tidigare emissioner
Pressrum
Pressmeddelanden
Eventkalender
Analyser och presentationer
Prenumerera
Kontakt
Eng
Sök
Analyser och presentationer
Bolagspresentation
Bolagspresentation
oktober 2024
Analyser
16 okt. 2024 / Pensery Access by Carnegie - 16 oktober 2024
https://guardtherapeutics.com/assets/uploads/Penser20241016.pdf
11 okt. 2024 / 4 minutes with Penser Access by Carnegie
https://youtu.be/hhcHRGzHSIA
23 aug. 2024 / Penser Access by Carnegie - 23 augusti 2024
https://guardtherapeutics.com/assets/uploads/Penser20240823.pdf
08 aug. 2024 / Penser Access by Carnegie - 8 augusti 2024
https://guardtherapeutics.com/assets/uploads/Penser20240808.pdf
18 juni 2024 / Penser Access by Carnegie - 18 juni 2024
https://guardtherapeutics.com/assets/uploads/Penser20240618.pdf
23 feb. 2024 / Penser Access by Carnegie - 23 februari 2024
https://guardtherapeutics.com/assets/uploads/Penser20240223-Q4.pdf
Presentationer & intervjuer
13 nov. 2024 / Intervju med vd Tobias Agervald i samband med delårsrapport kvartal 3 2024
https://youtu.be/qBcgYd5hkp0
17 okt. 2024 / Guard presenterar på Redeyes temadag "Cardiovascular & Metabolic Diseases Event 2024"
https://www.redeye.se/videoiframe/1044029
17 okt. 2024 / Vd Tobias Agervald medverkar i Penserpodden by Carnegie
https://open.spotify.com/episode/55ZozQaGCAYTB9gLRFzPLI?si=e3464f4047754b94
23 sep. 2024 / Vd Tobias Agervald intervjuas av BiotechTV
https://www.biotechtv.com/post/guard-therapeutics-september-21-2024
19 sep. 2024 / Presentation från Pareto Securities' 15th Annual Healthcare Conference
https://guardtherapeutics.com/assets/uploads/Guard-Tx-Pareto-19Sept2024-final.pdf
03 sep. 2024 / Intervju med VD Tobias Agervald i samband med start av Pointer-studien
https://youtu.be/rP_XacWmzN8